Search research articles
Contact Us
Filters
Showing results (91-100 of 100) with videos related to
Page
of 10
Sort By:
You have reached the last page of results.
This site can display upto 100 results.
Drug Metabolism Reviews
|
July 4, 2024
Bioactivation and reactivity research advances - 2023 year in review
Shuai Wang, Upendra A Argikar, Maria Chatzopoulou, et al.
Drug Metabolism Reviews
|
August 23, 2023
Bioactivation and reactivity research advances - 2022 year in review‡
Shuai Wang, Upendra A Argikar, Lionel Cheruzel, et al.
Drug Metabolism Reviews
|
September 22, 2023
Biotransformation research advances - 2022 year in review
S Cyrus Khojasteh, Upendra A Argikar, Lionel Cheruzel, et al.
Journal of Medicinal Chemistry
|
August 4, 2021
Structure-Based Optimization of ML300-Derived, Noncovalent Inhibitors Targeting the Severe Acute Respiratory Syndrome Coronavirus 3CL Protease (SARS-CoV-2 3CL<sup>pro</sup>)
Sang Hoon Han, Christopher M Goins, Tarun Arya, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy
|
September 1, 1996
A phase I randomized study of subcutaneous adjuvant IL-2 in combination with an autologous tumor vaccine in patients with advanced renal cell carcinoma
R G Fenton, R G Steis, K Madara, et al.
The Journal of Investigative Dermatology
|
September 16, 2023
Phototherapy Restores Deficient Type I IFN Production and Enhances Antitumor Responses in Mycosis Fungoides
Zizi Yu, Pablo Vieyra-Garcia, Theresa Benezeder, et al.
RSC Medicinal Chemistry
|
January 22, 2021
Identification of 6-amino-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidines with <i>in vivo</i> efficacy against visceral leishmaniasis
Michael G Thomas, Manu De Rycker, Myriam Ajakane, et al.
ACS Chemical Neuroscience
|
December 11, 2024
Discovery of VU0467319: an M<sub>1</sub> Positive Allosteric Modulator Candidate That Advanced into Clinical Trials
Michael S Poslunsey, Michael R Wood, Changho Han, et al.
Journal of Medicinal Chemistry
|
August 29, 2017
Discovery and Optimization of 5-Amino-1,2,3-triazole-4-carboxamide Series against Trypanosoma cruzi
Stephen Brand, Eun Jung Ko, Elisabet Viayna, et al.
Journal of Medicinal Chemistry
|
December 21, 2018
Identification of GSK3186899/DDD853651 as a Preclinical Development Candidate for the Treatment of Visceral Leishmaniasis
Michael G Thomas, Manu De Rycker, Myriam Ajakane, et al.
Page
of 10
Search research articles
Search
Showing results (91-100 of 100) with videos related to
Sort By:
Page
of 10
You have reached the last page of results.
This site can display upto 100 results.
Drug Metabolism Reviews
|
July 4, 2024
Bioactivation and reactivity research advances - 2023 year in review
Shuai Wang, Upendra A Argikar, Maria Chatzopoulou, et al.
Drug Metabolism Reviews
|
August 23, 2023
Bioactivation and reactivity research advances - 2022 year in review‡
Shuai Wang, Upendra A Argikar, Lionel Cheruzel, et al.
Drug Metabolism Reviews
|
September 22, 2023
Biotransformation research advances - 2022 year in review
S Cyrus Khojasteh, Upendra A Argikar, Lionel Cheruzel, et al.
Journal of Medicinal Chemistry
|
August 4, 2021
Structure-Based Optimization of ML300-Derived, Noncovalent Inhibitors Targeting the Severe Acute Respiratory Syndrome Coronavirus 3CL Protease (SARS-CoV-2 3CL<sup>pro</sup>)
Sang Hoon Han, Christopher M Goins, Tarun Arya, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy
|
September 1, 1996
A phase I randomized study of subcutaneous adjuvant IL-2 in combination with an autologous tumor vaccine in patients with advanced renal cell carcinoma
R G Fenton, R G Steis, K Madara, et al.
The Journal of Investigative Dermatology
|
September 16, 2023
Phototherapy Restores Deficient Type I IFN Production and Enhances Antitumor Responses in Mycosis Fungoides
Zizi Yu, Pablo Vieyra-Garcia, Theresa Benezeder, et al.
RSC Medicinal Chemistry
|
January 22, 2021
Identification of 6-amino-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidines with <i>in vivo</i> efficacy against visceral leishmaniasis
Michael G Thomas, Manu De Rycker, Myriam Ajakane, et al.
ACS Chemical Neuroscience
|
December 11, 2024
Discovery of VU0467319: an M<sub>1</sub> Positive Allosteric Modulator Candidate That Advanced into Clinical Trials
Michael S Poslunsey, Michael R Wood, Changho Han, et al.
Journal of Medicinal Chemistry
|
August 29, 2017
Discovery and Optimization of 5-Amino-1,2,3-triazole-4-carboxamide Series against Trypanosoma cruzi
Stephen Brand, Eun Jung Ko, Elisabet Viayna, et al.
Journal of Medicinal Chemistry
|
December 21, 2018
Identification of GSK3186899/DDD853651 as a Preclinical Development Candidate for the Treatment of Visceral Leishmaniasis
Michael G Thomas, Manu De Rycker, Myriam Ajakane, et al.
Page
of 10